Last reviewed: June 4, 2026
Last updated: June 4, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
The question 'how overweight do I need to be for GLP-1?' reflects a common misconception that weight loss medications follow strict size cutoffs. In reality, medical eligibility depends on body mass index (BMI), health conditions, and individual risk factors—not a single number on the scale. PlexusDx works with licensed prescribers to evaluate each patient's unique metabolic profile and determine whether GLP-1 therapy aligns with evidence-based treatment guidelines.
GLP-1 Eligibility Requirements: BMI and Medical Criteria
Current clinical guidelines do not mandate a minimum weight for GLP-1 receptor agonist therapy. Instead, prescribers evaluate two primary eligibility pathways. First, patients with a BMI of 30 kg/m² or higher (or 27+ with weight-related comorbidities like hypertension or type 2 diabetes) may qualify based on weight alone. Second, individuals below these thresholds but with metabolic dysfunction, insulin resistance, or obesity-related health conditions can still be candidates if medically appropriate.
The goal of this flexible approach is to identify patients most likely to benefit from appetite regulation and improved metabolic function. A licensed prescriber reviews your complete health history—medications, blood pressure, glucose levels, family history, and current symptoms—rather than relying solely on body composition. This personalized evaluation ensures that GLP-1 therapy addresses your specific metabolic needs, not just a number.
Why BMI Thresholds Vary: Health Conditions and Risk Factors
A person with a BMI of 28 and uncontrolled blood sugar may qualify for semaglutide, while another with a BMI of 32 and no metabolic concerns might not. This variation reflects the reality that weight alone does not predict health risk or treatment benefit. Conditions like insulin resistance, polycystic ovary syndrome (PCOS), metabolic syndrome, and cardiovascular disease lower the BMI threshold for eligibility because GLP-1 medications address the underlying metabolic dysfunction driving these conditions.
Prescription guidelines also account for previous weight loss attempts. Patients who have struggled with conventional diet and exercise approaches, or those with a family history of obesity and type 2 diabetes, often meet criteria at lower BMI levels. PlexusDx works with prescribers to document these clinical factors, ensuring your treatment decision is grounded in evidence rather than arbitrary cutoffs.
PlexusDx Semaglutide Injection: Affordable Access Without Insurance Requirements
Once a licensed prescriber determines your eligibility, PlexusDx provides access to compounded semaglutide injection through licensed 503A compounding pharmacies starting at $149 per month. This flat pricing model means your dose may need to increase as your body adapts, but your monthly cost remains stable—a key advantage over traditional retail pharmacy pricing. PlexusDx serves all 50 states, requires no insurance, no membership fees, and accepts HSA and FSA funds.
The compounding process allows for personalized dosing precision and flexibility that standard mass-produced medications cannot match. Each injection is prepared according to your prescriber's exact specifications, ensuring consistency and quality from a licensed pharmacy. This approach eliminates the insurance barrier that delays or prevents many patients from accessing GLP-1 therapy, making evidence-based weight loss medication accessible within weeks rather than months.
Precision Peptide Genetic Testing: Understanding Your Metabolic Response
Beyond BMI and health history, your genetic makeup influences how effectively GLP-1 medications work for you. PlexusDx offers the Precision Peptide Genetic Test—a peptide-pathway genetic assessment that examines 49 peptides across 14 metabolic pathways and 150+ genetic insights. Key variants in the GLP1R gene (rs6923761), GIPR gene (rs1800437), FTO gene (rs9939609), and MC4R gene (rs17782313) help predict your individual response to semaglutide and other GLP-1 therapies.
This $99 add-on test (available after your first month of treatment) informs your prescriber whether semaglutide alone will optimize your weight loss and metabolic health, or whether a dual-compound therapy like GLP-Squared (combining semaglutide and tirzepatide) may yield better results. Genetic insights transform GLP-1 therapy from a one-size-fits-all approach into a truly personalized treatment protocol tailored to your metabolic biology.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Do I have to weigh a certain amount to qualify for GLP-1 therapy?
No. While a BMI of 30+ is one common indicator, medical eligibility depends on your overall health profile—BMI, metabolic conditions, and previous weight loss attempts. A licensed prescriber evaluates all factors to determine whether GLP-1 is appropriate for you, not a single weight threshold. PlexusDx connects you with prescribers who perform t...
What clinical evidence supports GLP-1 therapy for weight loss?
Landmark trials show that semaglutide reduces body weight by 10-15% on average, with effects on appetite regulation, satiety signals, and metabolic rate. Tirzepatide (a dual GLP-1/GIP agonist) achieves 15-22% weight reduction. These results hold across diverse patient populations, including those without type 2 diabetes. The evidence base suppor...
How much does PlexusDx semaglutide injection cost?
Compounded semaglutide injection from PlexusDx starts at $149 per month with flat pricing—your dose may increase, but your price won't. No insurance is required, and HSA/FSA funds are accepted. Service is available across all 50 states with no membership fees.
Are compounded GLP-1 medications as safe as FDA-approved versions?
PlexusDx sources all compounded medications from licensed 503A compounding pharmacies, which follow strict sterility, potency, and quality standards under FDA oversight. While compounded medications are not FDA-approved (the active ingredient is, but the specific formulation is not), 503A pharmacies operate within a well-established regulatory f...
How does the Precision Peptide Genetic Test help me?
The test identifies your genetic variants in GLP1R, GIPR, FTO, MC4R, and 45 other peptide pathways to predict how your body will respond to semaglutide or tirzepatide. This helps your prescriber choose the most effective compound and dose for your metabolism, avoiding trial-and-error and accelerating your weight loss results. The $99 add-on test...
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Do You Lose Weight with Tirzepatide?
The Journey of GLP-1 Medications: When Was the First GLP-1 Approved?